Avantor (NYSE:AVTR) Issues Quarterly Earnings Results

Avantor (NYSE:AVTR) issued its quarterly earnings results on Friday. The company reported $0.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.20 by $0.02, Briefing.com reports. Avantor had a return on equity of 14.11% and a net margin of 4.61%. The firm had revenue of $1.68 billion for the quarter, compared to analyst estimates of $1.68 billion. During the same period in the previous year, the firm earned $0.29 earnings per share. The company’s revenue was down 5.6% compared to the same quarter last year.

Avantor Price Performance

AVTR traded down $1.21 during trading on Friday, reaching $23.94. 14,185,165 shares of the company were exchanged, compared to its average volume of 4,145,237. The company’s 50-day moving average is $25.08 and its two-hundred day moving average is $22.62. The company has a market cap of $16.24 billion, a price-to-earnings ratio of 61.38, a P/E/G ratio of 2.44 and a beta of 1.37. The company has a quick ratio of 1.05, a current ratio of 1.61 and a debt-to-equity ratio of 1.00. Avantor has a 12-month low of $16.63 and a 12-month high of $26.16.

Insider Buying and Selling

In related news, EVP James Bramwell sold 6,203 shares of the stock in a transaction dated Tuesday, February 27th. The stock was sold at an average price of $24.49, for a total transaction of $151,911.47. Following the sale, the executive vice president now owns 101,143 shares of the company’s stock, valued at approximately $2,476,992.07. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 1.50% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on AVTR. Deutsche Bank Aktiengesellschaft upped their target price on Avantor from $23.00 to $25.00 and gave the stock a “hold” rating in a research report on Thursday, April 18th. Citigroup upped their target price on Avantor from $24.00 to $30.00 and gave the stock a “buy” rating in a research report on Thursday, February 15th. Barclays upped their target price on Avantor from $27.00 to $30.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 10th. Raymond James upped their price target on Avantor from $22.50 to $26.00 and gave the stock an “outperform” rating in a report on Friday, January 26th. Finally, Evercore ISI upped their price target on Avantor from $26.00 to $28.00 and gave the stock an “outperform” rating in a report on Thursday, April 4th. Four analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat, Avantor currently has an average rating of “Moderate Buy” and a consensus price target of $26.71.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.